0
en
US
Free Shipping on Orders Above $25
× Supersmart Learn by health topic New articles Popular articles Visit our shop My account Smart Prescription Blog Loyalty program Language: English
Immune system, fatigue and infections Guides and tutorials

Flu, Covid and bronchiolitis: how to tell them apart and how to treat them

This winter, we’re facing a particularly virulent triple epidemic of respiratory viruses. How can you tell these various illnesses apart, and how can you prevent and treat them?
Flu or Covid patient
Hang in there!
Rédaction Supersmart.
2023-01-18Commentaires (0)

Influenza: definition, symptoms and treatments

Influenza or flu is a contagious respiratory illness transmitted by an influenza virus. Usually mild, its symptoms include a high fever above 38.5 °C, dry cough, headache, aching muscles and intense fatigue (1-2).

In more vulnerable groups, however, such as new-born babies, those over 65 or immune-compromised individuals, it can cause serious complications (lung failure, exacerbation of chronic bronchitis, decompensation of asthma) (3).

The incubation period for flu is between 1 and 3 days. A person is contagious from the day before symptoms appear and may continue to be for up to a week. The virus is transmitted via airborne droplets (saliva and nasal secretions in coughs and sneezes) and also indirectly through touching contaminated surfaces (4).

Flu epidemics normally start in winter due to three conjunctive factors: we spend more time indoors in close proximity to others, our nasal mucous membranes become drier making it easier for the virus to invade, and the flu virus may survive better in the cold (5).

As most people recover by themselves, treatments are aimed at easing symptoms only - staying well-hydrated and taking painkillers and medication to reduce the fever and cough. Antivirals may be prescribed for more vulnerable individuals to prevent progression to more serious illness (6).

Covid-19: how it differs from the flu

First appearing in December 2019 in China’s Wuhan province, Covid-19 (which stands for COronaVIrus Disease 2019) is a viral respiratory infection transmitted by the SARS-CoV-2 coronavirus (7).

A feature of the Covid-19 virus is the wide variety of symptoms it produces (8). While some people remain asymptomatic, others display classic symptoms of a respiratory infection, such as fever or cough, combined perhaps with muscle pain, headache, sore throat or nasal congestion. In such cases, it’s particularly hard to distinguish it from the flu.

However, there are certain characteristics which are much more suggestive of a Covid infection, such as loss of taste (ageusia) or smell (anosmia) (9). Digestion-related problems (nausea, vomiting, diarrhea…) or skin issues (redness, rashes, chilblain-like symptoms…) have also been reported (10).

In more severe forms, which usually develop in the second week of infection, pulmonary tract symptoms may be associated with hyperinflammatory syndrome, causing shortness of breath (dyspnoea) and oxygen desaturation, which require the patient to be hospitalised (11).

Covid-19 also has a longer incubation period than flu (5-8 days) and a contagion period which starts 2-3 days before the first symptoms appear (12). Transmission gradually decreases until the 7th day of symptoms, but in exceptional cases, may continue until the 14th day.

It is transmitted in the same way as flu, namely by airborne droplets spread by coughing or sneezing, or by contact with contaminated surfaces. Hence the introduction of barrier measures (face masks, social distancing, washing hands with alcohol-based sanitizers…)

For mild to moderate forms, there is no recommended treatment, though paracetamol can be taken in order to bring down the temperature. However, non-steroidal anti-inflammatories or NSAIDs (such as Ibuprofen) are not recommended as they can reduce the body’s immune response. As of February 2022, doctors have been able to prescribe an anti-viral treatment (Paxlovid®) to those at higher risk of complications (13).

Bronchiolitis: the common infant infection

Bronchiolitis is a viral respiratory illness affecting the bronchioles (small bronchi). It is generally caused by an RSV (respiratory syncytial virus) (14).

Usually mild, it primarily affects babies and children under 2 during the winter period. It normally starts with a simple cold and mild cough. The coughing fits get worse over a few days before gradually improving. They may be accompanied by wheezing or difficulty breathing, and even fever. The child sometimes finds it hard to sleep or eat(15).

The virus can also affect older children and adults but without causing any symptoms, or at worst, a slight cold. However, it is still highly contagious and spreads silently among the population. It is easily transmitted by saliva, coughing and sneezing, and also remains on hands and objects (dummies, security blankets, toys…).

If you’re a parent of a baby or young child, there are specific steps you can take to prevent the spread of bronchiolitis (16):

Fortunately, babies and childrennormally recover by themselves within 5-10 days though the cough may persist for 2-4 weeks. Treatment essentially consists of regularly clearing the nasal passages and feeding smaller amounts more frequently.

Hospitalisation is not usually necessary, except in the case of worsening symptoms in babies either aged less than 6 months, born prematurely or suffering from respiratory or heart disease.

A few tips for preventing illness and supporting your immune system

You can help avoid and stop the spread of winter viruses by adopting the following good habits:

References

  1. Vabret A, Dina J, Cuvillon-Nimal D, Nguyen E, Gouarin S, Petitjean J, Brouard J, Freymuth F. La grippe saisonnière [Seasonal flu]. Pathol Biol (Paris). 2010 Apr;58(2):e51-7. French. doi: 10.1016/j.patbio.2010.01.009. Epub 2010 Mar 19. PMID: 20303676; PMCID: PMC7126553.
  2. Boktor SW, Hafner JW. Influenza. [Updated 2022 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459363/
  3. Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ. 2016 Dec 7;355:i6258. doi: 10.1136/bmj.i6258. PMID: 27927672; PMCID: PMC5141587.
  4. Moghadami M. A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci. 2017 Jan;42(1):2-13. PMID: 28293045; PMCID: PMC5337761.
  5. Fong MW, Gao H, Wong JY, Xiao J, Shiu EYC, Ryu S, Cowling BJ. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures. Emerg Infect Dis. 2020 May;26(5):976-984. doi: 10.3201/eid2605.190995. Epub 2020 May 17. PMID: 32027585; PMCID: PMC7181908.
  6. Robson C, Baskar SR, Booy R, Ferguson PE, Gilroy N, Kok J, Sandaradura I, Dwyer D. Influenza: overview on prevention and therapy. Aust Prescr. 2019 Apr;42(2):51-55. doi: 10.18773/austprescr.2019.013. Epub 2019 Apr 1. Erratum in: Aust Prescr. 2019 Jun;42(3):115. PMID: 31048938; PMCID: PMC6478960.
  7. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020 Jun 24;33(4):e00028-20. doi: 10.1128/CMR.00028-20. PMID: 32580969; PMCID: PMC7405836.
  8. Cascella M, Rajnik M, Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19) [Updated 2022 Oct 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
  9. Mullol J, Alobid I, Mariño-Sánchez F, Izquierdo-Domínguez A, Marin C, Klimek L, Wang DY, Liu Z. The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries. Curr Allergy Asthma Rep. 2020 Aug 3;20(10):61. doi: 10.1007/s11882-020-00961-1. PMID: 32748211; PMCID: PMC7397453.
  10. Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle). 2021 Feb;10(2):51-80. doi: 10.1089/wound.2020.1309. Epub 2020 Oct 19. PMID: 33035150; PMCID: PMC8020517.
  11. Hu J, Wang Y. The Clinical Characteristics and Risk Factors of Severe COVID-19. 2021;67(3):255-266. doi: 10.1159/000513400. Epub 2021 Jan 6. PMID: 33406518; PMCID: PMC7900480.
  12. Quesada JA, López-Pineda A, Gil-Guillén VF, Arriero-Marín JM, Gutiérrez F, Carratala-Munuera C. Incubation period of COVID-19: A systematic review and meta-analysis. Rev Clin Esp (Barc). 2021 Feb;221(2):109-117. doi: 10.1016/j.rceng.2020.08.002. Epub 2020 Nov 28. PMID: 33998486; PMCID: PMC7698828.
  13. Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, Goldstein LH, Saliba W. Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients. Clin Infect Dis. 2022 Jun 2:ciac443. doi: 10.1093/cid/ciac443. Epub ahead of print. PMID: 35653428; PMCID: PMC9214014.
  14. Justice NA, Le JK. Bronchiolitis. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441959/
  15. Erickson EN, Bhakta RT, Mendez MD. Pediatric Bronchiolitis. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519506/
  16. Drysdale SB, Green CA, Sande CJ. Best practice in the prevention and management of paediatric respiratory syncytial virus infection. Ther Adv Infect Dis. 2016 Apr;3(2):63-71. doi: 10.1177/2049936116630243. Epub 2016 Feb 10. PMID: 27034777; PMCID: PMC4784570.
  17. Toney-Butler TJ, Gasner A, Carver N. Hand Hygiene. [Updated 2022 Aug 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470254/
  18. Liang M, Gao L, Cheng C, Zhou Q, Uy JP, Heiner K, Sun C. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Jul-Aug;36:101751. doi: 10.1016/j.tmaid.2020.101751. Epub 2020 May 28. PMID: 32473312; PMCID: PMC7253999.
  19. Ferrari S, Blázquez T, Cardelli R, Puglisi G, Suárez R, Mazzarella L. Ventilation strategies to reduce airborne transmission of viruses in classrooms: A systematic review of scientific literature. Build Environ. 2022 Aug 15;222:109366. doi: 10.1016/j.buildenv.2022.109366. Epub 2022 Jul 7. PMID: 35818484; PMCID: PMC9259197.
  20. Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, Apostolopoulos V, Stojanovska L. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021 Jan;143:1-9. doi: 10.1016/j.maturitas.2020.08.003. Epub 2020 Aug 9. PMID: 33308613; PMCID: PMC7415215.
  21. Shaik-Dasthagirisaheb YB, Varvara G, Murmura G, Saggini A, Caraffa A, Antinolfi P, Tete' S, Tripodi D, Conti F, Cianchetti E, Toniato E, Rosati M, Speranza L, Pantalone A, Saggini R, Tei M, Speziali A, Conti P, Theoharides TC, Pandolfi F. Role of vitamins D, E and C in immunity and inflammation. J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):291-5. PMID: 23830380.
  22. Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch. 2012 Jan;463(1):121-37. doi: 10.1007/s00424-011-1044-0. Epub 2011 Nov 10. PMID: 22071480; PMCID: PMC3256323.
SharePinterest

Commentaires

You must be connected to your account to leave a comment
Be the first to review this article
Our selection of articles

Products which must be of interest

© 1997-2023 Fondation pour le Libre Choix. All rights reserved
© 1997-2023 Fondation pour le Libre Choix. All rights reserved
Nortonx
secure
Warning
ok